Skip to main content

. 1992 Jun;36(6):1342–1343. doi: 10.1128/aac.36.6.1342

Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever.

R Ruiz Beltrán, J I Herrero Herrero

PMCID: PMC190344 PMID: 1416836

1342

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bourgeade A., Jean-Pastor M. J., Raoult D. Notes sur la fièvre boutonneuse méditerranéenne (à propos de 40 cas récents, a Marseille). Bull Soc Pathol Exot Filiales. 1979 Jul-Aug;72(4):308–314. [PubMed] [Google Scholar]
HARRELL G. T. Treatment of Rocky Mountain spotted fever with antibiotics. Ann N Y Acad Sci. 1952 Dec 30;55(6):1027–1042. doi: 10.1111/j.1749-6632.1952.tb22662.x. [DOI] [PubMed] [Google Scholar]
Marcos Sánchez F., Turabian Fernández J. L., Moreiras Jiménez J. L., Gorgolas Hernández P., Durán Pérez-Navarro A. Fiebre botonosa mediterránea. Trimetoprim-sulfametoxazol tratamiento de elección. Med Clin (Barc) 1983 Jul 16;81(5):236–236. [PubMed] [Google Scholar]
Raoult D. Antibiotic susceptibility of rickettsia and treatment of rickettsioses. Eur J Epidemiol. 1989 Dec;5(4):432–435. doi: 10.1007/BF00140135. [DOI] [PubMed] [Google Scholar]
Raoult D., Drancourt M. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother. 1991 Dec;35(12):2457–2462. doi: 10.1128/aac.35.12.2457. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES